Mary Bythell
Overview
Explore the profile of Mary Bythell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
392
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mumford L, Hogg R, Taylor A, Lanyon P, Bythell M, McPhail S, et al.
Lancet
. 2025 Jan;
405(10475):314-328.
PMID: 39863371
Background: In the UK, booster COVID-19 vaccinations have been recommended biannually to people considered immune vulnerable. We investigated, at a population level, whether the absence of detectable anti-SARS-CoV-2 spike protein...
2.
Pearce F, Lim S, Bythell M, Lanyon P, Hogg R, Taylor A, et al.
Lancet Rheumatol
. 2024 Jan;
5(8):e461-e473.
PMID: 38251578
Background: In the UK, additional COVID-19 vaccine booster doses and treatments are offered to people who are immunosuppressed to protect against severe COVID-19, but how best to choose the individuals...
3.
West J, Stilwell P, Liu H, Ban L, Bythell M, Card T, et al.
J Hematol Oncol
. 2023 May;
16(1):56.
PMID: 37237311
Haemophagocytic lymphohistiocytosis (HLH) is a lethal syndrome of excessive immune activation. We undertook a nationwide study in England of all cases of HLH diagnosed between 2003 and 2018, using linked...
4.
Rutter M, Lanyon P, Grainge M, Hubbard R, Bythell M, Stilwell P, et al.
Rheumatology (Oxford)
. 2023 Apr;
62(12):3828-3837.
PMID: 37018139
Objectives: To calculate the rates of COVID-19 infection and COVID-19-related death among people with rare autoimmune rheumatic diseases (RAIRD) during the second wave of the COVID-19 pandemic in England, and...
5.
Odingo M, Rutter M, Bowley J, Peach E, Lanyon P, Grainge M, et al.
Rheumatology (Oxford)
. 2023 Jan;
62(9):3117-3125.
PMID: 36715615
Objective: To describe the incidence of Kawasaki Disease (kDa) between 2006 and 2021 in England. Methods: We identified all cases in hospital episode statistics with an ICD-10 diagnostic code M303...
6.
Hannah J, Gordon P, Galloway J, Rutter M, Peach E, Rooney M, et al.
Rheumatol Adv Pract
. 2022 Dec;
6(3):rkac102.
PMID: 36532317
Objective: Hospital episode statistics (HES) are routinely recorded at every hospital admission within the National Health Service (NHS) in England. This study validates diagnostic ICD-10 codes within HES as a...
7.
West J, Stilwell P, Liu H, Ban L, Bythell M, Card T, et al.
Hemasphere
. 2022 Nov;
6(11):e797.
PMID: 36340911
Hemophagocytic lymphohistiocytosis (HLH) is rare, results in high mortality, and is increasingly being diagnosed. We aimed to quantify the incidence of diagnosed HLH and examine temporal trends in relation to...
8.
Liu H, Stiller C, Crooks C, Rous B, Bythell M, Broggio J, et al.
Br J Haematol
. 2022 Sep;
199(5):728-738.
PMID: 36122574
This analysis is the largest population-based study to date to provide contemporary and comprehensive epidemiological estimates of all third edition of the International Classification of Diseases for Oncology (ICD-O-3) coded...
9.
West J, Card T, Bishton M, Lanyon P, Ban L, Bythell M, et al.
J Intern Med
. 2021 Dec;
291(4):493-504.
PMID: 34875131
Background: Haemophagocytic lymphohistiocytosis (HLH) is a rare hyper-inflammatory condition with poor outcomes. Objectives: Few population-based estimates of the incidence and survival in adults exist. We aimed to provide these data...
10.
Rutter M, Lanyon P, Grainge M, Hubbard R, Peach E, Bythell M, et al.
Rheumatology (Oxford)
. 2021 Oct;
61(8):3161-3171.
PMID: 34698821
Objectives: To calculate the rates of COVID-19 infection and COVID-19-related death among people with rare autoimmune rheumatic diseases (RAIRD) during the first wave of the COVID-19 pandemic in England compared...